Rosetta Genomics Ltd. — Form D/A

Rosetta Genomics Ltd. of REHOVOT, L3, a company, filed a Form D amendment with the SEC on 2011-03-07. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Kenneth BerlinDirectorMonmouth Junction, NJ
Yoav Shoshani CheloucheDirectorRehovot, L3
Moshe Shoshani ManyDirectorRehovot, L3
Tina Fishman EdmonstonExecutive OfficerRehovot, L3
Racheli Shoshani VizmanExecutive OfficerRehovot, L3
David SidranskyDirectorGermantown, MD
BRIAN MARKISONDirectorROCKVILLE, MD
Oded BiranExecutive OfficerSouthborough, MA
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Tali Yaron-EldarDirectorTel Aviv, L3
Ranit AharonovExecutive OfficerRehovot, L3
Joshua RosensweigDirectorRehovot, L3
Tomer AssisExecutive OfficerRehovot, L3
Gerald DogonDirectorRehovot, L3
Isaac Shoshani BentwichDirectorRehovot, L3
Joshua Shoshani RosensweigDirectorRehovot, L3
Tzipora Shoshani KupitzExecutive OfficerRehovot, L3
Gerald Shoshani DogonDirectorRehovot, L3
Tami Fishman JutkowitzExecutive OfficerRehovot, L3
Brian A MarkisonDirectorRehovot, L3
David Shoshani SidranskyDirectorRehovot, L3
Tali Shoshani Yaron-EldarDirectorRehovot, L3
Keren GivliExecutive OfficerRehovot, L3
Ayelet ChajutExecutive OfficerRehovot, L3

Other filings by this issuer (5)

FiledFormOfferingSold
2012-02-09D$1.8M$1.8M
2011-11-01D$1.9M$1.5M
2011-03-07D/A$2.5M$2.5M
2011-03-03D$2.7M$2.7M
2011-03-03D$2.5M$2.5M

More